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Abstract 
It is estimated that by 2001 20 million people had died from AIDS, which is now 
the world’s fourth biggest cause of death. While the highest prevalence and death 
rates and number of infected persons are reported for sub-Saharan Africa, where 
life expectancies at birth are declining rapidly and infant mortality rates are 
increasing, there is evidence that the epidemic is accelerating in Asia and Eastern 
Europe. While the human and social costs of the HIV/AIDS epidemic are the 
major causes for concern, the econometric results reported in this paper indicate 
that the macroeconomic affects of the HIV/AIDS epidemic have been substantial; 
especially in Africa where the average marginal negative impact on income per 
capita of a one percent increase in HIV prevalence rate is 0.59 percent. Even in 
countries where the HIV prevalence rates are lower the marginal impacts are non 
trivial. 
Keywords: AIDS; Growth; Human Capital; Panel Data. 
JEL classification: O15; O47; I12; C23. 
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1. Introduction 
“Twenty years after the first clinical evidence of acquired immunodeficiency 
syndrome was reported, AIDS has become the most devastating disease 
humankind has ever faced. Since the epidemic began, more than 60 million people 
have been infected with the virus. HIV/AIDS is now the leading cause of death in 
sub-Saharan Africa. Worldwide it is the fourth-biggest killer.” (UNAIDS/WHO, 
2001) 
It is estimated that in 2003 about 5 million more people acquired the HIV virus and that more 
3 million people died from AIDS1 bringing total deaths from the epidemic to more than 25 
million (UNAIDS, 2003). While the highest prevalence and death rates and number of 
infected persons are reported for sub-Saharan Africa, there is evidence that the epidemic is 
accelerating in Asia and Eastern Europe and that complacency is causing an upturn in 
prevalence in North America and Western Europe. Wherever the epidemic strikes it imposes 
severe human and social consequences. Family life is severely disrupted as adults are 
rendered less able and/or unable to work, health care costs rise and children are forced 
prematurely onto the labour market and/or made orphans. These human and social 
consequences of the epidemic, especially in sub-Saharan Africa, are increasingly visible as 
the media devotes resources to covering the epidemic. Over and above these consequences are 
the economic costs of the epidemic. These include immediate costs, such as increased health 
care expenditures and reduced labour productivity, and long term costs, such as reduced levels 
of education, health, physical and social capital. 
Since few economists would doubt the potential of the AIDS epidemic to create 
substantial economic costs, it is surprising that there have been relatively few studies into the 
economic, especially the macroeconomic, implications of the epidemic (see below).2 In part 
this is probably a reflection of the limited recognition given to the impact of health upon 
macroeconomic performance and the relatively recent availability of data that allow 
systematic econometric evaluations of the epidemic. The results reported in this paper are 
based upon an augmented Solow model that incorporates both health and education capital. 
Importantly, the model is estimated as a system wherein health capital is partially determined 
by health status, in particular the prevalence of HIV infection, using panel data. The next 
section briefly reviews the literature on HIV/AIDS and development. Section 3 summarises 
                                                 
1 Of the 37.8 million people estimated to be living with HIV at the end of 2003 17 million were women and 
2.1 million were children under 15 (UNAIDS, 2004). The proportions of women and children infected in 
sub-Saharan Africa are greater. 
2 The UK Parliament’s House of Commons International Development Committee recently commented on 
the lack of information about the macroeconomic impact of HIV/AIDS (International Development 
Committee, 2001). 
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the derivation of the growth and health capital equations, and comments on the panel data 
methods. Section 4 starts with a discussion of the available data and how they influence the 
specification of the estimating equations, and then reports the results. The results are 
discussed in section 5 and the final section contains concluding comments. 
2. HIV/AIDS and Development 
Empirical analyses of the macroeconomic impact of the epidemic have been based largely 
upon standard neoclassical growth models. In the context of these models the epidemic would 
be expected to reduce productive efficiency, and hence output per worker, reduce the rate of 
growth of the labour force and lower the savings rate. Cuddington (1993, pp 178-1) 
demonstrates that in a simple neoclassical growth model the epidemic may cause per capita 
income and the capital-labour ratio to either increase or decrease because the labour force and 
savings rate effects operate in opposite directions. Hence it is arguable that the net impact of 
the epidemic upon economic growth is an empirical question. 
Quantitative estimates in the early 1990s were compromised by a lack of appropriate data, 
and hence to a greater or lesser extent calibrated growth models were used to derive estimates 
of the macroeconomic effects of the epidemic. All known studies of this type have examined 
the impact of HIV/AIDS on individual countries. Over (1992) estimated that between 1990 
and 2025 the 10 countries with the most advanced epidemics would see a reduction in growth 
per capita of around a third of a percentage point compared to a non-AIDS scenario. 
Similarly, Cuddington and Hancock (1994) suggest that between 1985 and 2010 Malawi 
could experience average real GDP growth up to 1.5 percentage points lower, while 
Cuddington (1993) estimates that in Tanzania per capita GDP could be up to 10% smaller. 
More recently two studies have focused on Botswana (BIDPA, 2000; and MacFarlan and 
Sgherri, 2001), with both using variants of calibrated neoclassical growth models. MacFarlan 
and Sgherri concluded that GDP growth in Botswana would decline from around 5.5 percent 
to between 1.5 and 2.5 percent per annum as a result of the epidemic, and would have ‘non-
negligible’ impacts across production sectors, households and labour types while placing 
substantial burdens on the government budget. 
However there have been very few cross-country statistical studies. Bloom and Mahal 
(1997) concluded, “there is more flash than substance to the claim that AIDS impedes 
national economic (income) growth.” (p 120), while acknowledging that the negative impact 
on life expectancy may affect development. There are reasons related to the data to doubt the 
robustness of Bloom and Mahal’s results. The empirical estimates were based on data for the 
period 1980-92, when prevalence estimates were typically one seventh to one fifth of those 
now produced. Furthermore, the AIDS epidemic was still in its early stages and hence its 
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impacts upon morbidity and mortality were still relatively restrained. Given the data 
limitations it is not surprising that Bloom and Mahal’s sample was constrained to 51 
countries, although it is worrying that countries with high infection rates were not included, 
e.g., South Africa, Botswana, Rwanda, Namibia and Swaziland.3 There are also theoretical 
and statistical reasons to reevaluate Bloom and Mahal’s results (see below). 
More recently, Bonnel (2000) concluded, from a cross-country study using African data, 
that HIV/AIDS on average reduced Africa’s per capita growth rate by 0.7 percent points, 
which is substantial given an average growth rate in the sample of 0.4 percent per annum per 
capita. Furthermore, if the countries were also affected by malaria, the growth rate was 
lowered by a further 0.3 percent points. These results were obtained using a cross-
section/cross-country growth equation estimated in a system with equations for policy 
variables and HIV. It would therefore seem that Bonnel’s work using more recent and 
comprehensive data are sufficient to cast doubt upon Bloom and Mahal’s earlier study. 
3. Growth and Human Capital 
The analyses reported in this paper are derivatives of the empirical research into economic 
growth that has developed since the late 1980s. The contribution of human capital to the 
growth process has been central in this research (Mankiw et al., 1992; Barro and Lee, 1993; 
Benhabib and Spiegel, 1994, among many others). Mankiw et al., (1992, p 408) augmented a 
neoclassical growth model with a human-capital variable to counter the misspecification bias 
that will arise if both physical and human capital exists and human capital is omitted from the 
estimating equation. But it has long been recognised in the literature that human capital is a 
complex input that consists of more than education and productive skills. Part of this literature 
has emphasised the importance of health capital as a dimension of human capital, e.g., 
Schultz, (1961); Mushkin, (1962); Dasgupta (1993). Hence any misspecification bias will 
only be partially addressed if other dimensions of human capital are not included in 
estimating equations. Nevertheless estimates of the effects of health on growth are limited, 
e.g., Hicks (1979), Wheeler (1980), Knowles and Owen (1995), Bhargava et al. (2002) and 
McDonald and Roberts (2002). The latter three studies have confirmed the empirical 
significance of health capital as a determinant of economic growth. 
It is still common in the empirical growth literature for estimating equations to be 
specified using the cross-country cross-section method, despite the well known potential 
weaknesses of this method. In particular, the need to impose the assumptions that there are 
common initial technologies, rates of technical progress and preferences across countries. 
Moreover the method discards potentially important information by collapsing dynamics. 
                                                 
3 Namibia is also excluded from the sample used in this study. 
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These issues can be addressed by adopting panel data methods and thereby explicitly testing 
the critical assumptions of the cross-section method by making use of information arising 
from variation across countries and over time. Most panel data studies relating to cross 
country economic growth have indicated that the results of cross-section studies may be 
suspect (Islam, 1995; Lee et al., 1997; Miller, 1996; Cellini, 1997; McDonald and Roberts, 
1996; 1999; 2002). 
An Augmented Solow Model4
Define the aggregate production function for the augmented Solow model as a Cobb-Douglas 
function with constant returns to scale and labour augmenting technical progress, and three 
types of capital as 
[ ] ψβαψβα itititititit HEKLAY −−−= 1  (1) 
where Y is output, A is technology, L is labour, K, E and H are respectively physical, 
education and health capital, α, β and ψ are the elasticities of output with respect to the 
various types of capital, and the subscripts denote country (i) and time (t). Equation (1) can be 
re-written in intensive form as 
it it it ity k e h
α β ψ=  (2) 
where yit is output per ‘effective’ labour unit ( )itit LA  in country i at time t, and , and  
are respectively physical, education and health capital per ‘effective’ labour unit.  
itk ite ith
Assuming that the labour forces grow at country specific constant rates ni, and 
technologies advance at period specific constant rates gt, and that the physical, education and 
human capital stocks depreciate at the same constant rate, δ,5 then it can be shown (see 
Appendix IV) that the augmented steady state output per capita ( ) is *ity
( )* 0ln ln ln(1 )
ln ln ln
(1 ) (1 ) (1 )
it i t i i
K E H
i i
y A g t n g
s s is
α β ψ δα β ψ
α β ψ
α β ψ α β ψ α β ψ
+ += + − + +− − −
+ + +− − − − − − − − −
 (3) 
and where ,  and K Ei i is s s
H
                                                
 are the savings rates devoted to physical, education and health 
capitals. Equation 3 is equivalent, except for the inclusion of a term for health capital, to 
Mankiw et al.’s equation 11 (p 417). 
 
4 This model was ‘developed’ in McDonald and Roberts (2002), which was itself a development of 
Knowles and Owen’s (1995) model. Both models follow a lead established by Mankiw et al., (1992). 
5 The use of a constant uniform depreciation rate follows Mankiw et al., (1992), who based their 
assumption upon estimates by Romer (1989); there remains inadequate data to estimate country specific 
rates. 
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Empirically (3) is difficult to implement because of an absence of disaggregated savings 
data. In general the available savings, or investment, data refer to physical capital, and 
estimates for education and health capital are likely to be missing. However underlying (3) is 
a steady-state condition in levels, which Mankiw et al., exploited to derive alternative 
formulations of the estimating equation according to whether the augmenting capital terms 
are recorded as rates of accumulation, as in equation 3, or as levels, e.g., 
( )* *0ln ln ln ln ln ln(1 ) (1 ) (1 ) (1 )K Eit i t i t i i ity A g t n g s s h
α α β ψδα α α= + − + + + + +− − − α−
 (4) 
where the asterisk indicates that the quantity of health capital per effective labour unit ( ) is 
a steady state level. While (3) is implicitly derived from a steady state expression in terms of 
levels, the derivation of (4) does require the presumption of a steady state. The choice of 
whether an estimating equation is based on (3) or some variant of (4) will depend typically 
upon the available data, and consequently the extent to which the presumption of an 
underlying steady state is restrictive is largely determined by the available data.
*
ith
6
Linearising (4) around the steady-state level of income per effective unit of labour, , 
following the method used by Mankiw et al., produces 
*
ity
( ) ( ) ( ) ( )
( ) ( ) ( )
* *
0 0
* *
0
1 exp 1 exp
ln ln 1 exp ln ln ln
(1 ) (1 )
1 exp 1 exp
ln ln 1 exp ln
(1 ) (1 )
t t
t K
it i i t i t i
t t
E t
i it
y y A g t n g
s h y
λ λ
λ
λ λ
λ
α αδα α
β ψ
α α
− −− = − + − + + +− −
− −+ + − −− − i
s
1
. (5) 
One substantive empirical advantage of the method used by Mankiw et al., is that it allows for 
the mixing of stock and saving/investment data for the capital components of the estimating 
equation. Solving (5) for , and using standard panel data notation, gives a general 
specification of the econometric growth model for which estimates are reported in this paper 
*ln ity
4
* *
0
1
j
it i j it t i it
j
z z xγ θ η µ
=
= + + + +∑ ν
                                                
 (6) 
where 
 
6 For instance McDonald and Roberts (2002) had estimates of the stock of education capital and therefore 
estimated a version of (4) where education capital was expressed in terms of the steady state levels. 
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and the 1itν  is the standard error term. 
Equation (6) differs from a typical cross-section estimating equation in several important 
ways: it allows for cross-time variations in the rates of growth of technology, gt, country 
specific initial states of technology, lnAi0, and uses the time series information by being 
estimated as a dynamic data panel with two-way fixed effects. In particular it facilitates 
testing of the identifying assumption for OLS estimation of the cross-section model, i.e., 
ε+= aAi0ln  (7) 
where a is a constant, invariant across countries, that all country differences are accounted for 
by the random term, ε, and that the stochastic term is independent of all other explanatory 
variables. Panel estimates of (6) using data for 1960 to 1989 (McDonald and Roberts, 2002) 
indicate that health capital has a positive, and often significant, impact upon economic 
growth. But these results were obtained using a model that takes the health capital terms as 
being exogenously determined, and use data for a period that overwhelmingly precedes the 
substantive onset of the HIV/AIDS epidemic. Moreover, the estimation technique did not 
account for the presence of a lagged dependent variable on the right hand side of the growth 
equation (6), which may lead to bias in the OLS estimates. 
The model in (6) differs appreciably from the estimating equations specified by Bloom 
and Mahal (1997) and Bonnel (2000). The variables included in the econometric growth 
equation are determined by the theoretical derivation of the model, which also provides the 
basis for a clear theoretical interpretation of the model that may be lost if additional 
explanatory variables are introduced. Most importantly, HIV/AIDS does not enter directly 
into the model. Rather, it is deemed preferable to identify relationships between the model’s 
explanatory variables and the prevalence or incidence of HIV/AIDS. Hence it is hypothesised 
that the impacts of diseases enter into the determination of growth indirectly through their 
impact upon both the population growth terms and the health capital terms. This requires a 
model wherein health capital is explained. 
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Health Capital 
Much of the research on the determinants of health capital stems from the household 
production function approach of Grossman (1972), which is a microeconomic formulation 
that is not readily applicable within a macroeconomic framework. Genberg (1992) has 
surveyed the literature on macroeconomics and health and concludes that “detailed 
relationships between macroeconomic change and health outcomes are not clearcut … and 
one is left with a set of associations relating the two sets of phenomena but no strong evidence 
of causality” (p.13).   
Given the primary aim of estimating the effects of HIV/AIDS on economic growth via a 
theoretically supported macroeconomic growth model and the absence of any settled body of 
theory on the determinants of health capital that can be applied at the macro level, the second-
best approach is to define a reduced form model for health capital. This reduced form 
postulates health capital as function of a set of exogenous (or predetermined) variables; the 
variables included are informed by the literature but do not represent a structural relationship 
between the chosen determinants and health capital.  
Grossman’s (1972) notion of health as a capital good suggests the inclusion of a lagged 
dependent variable, which requires a dynamic specification for the reduced form. There is 
evidence from both cross sectional studies (Preston, 1986; Hobcroft et al., 1984) and long 
time series (United Nations 1988; Hill 1987) that indicate that higher levels of income are 
associated with better health, and hence lagged per capita income is included as an 
explanatory variable.7 Education capital and nutritional status are also included, since there 
are reasons to believe that these are important determinants of health, especially in developing 
countries. HIV prevalence and the proportion of the population at risk of malaria are included 
to account for the major diseases and are considered to be exogenous health shocks since the 
presence of malaria is defined primarily by climate and topography.8 To account for possible 
lags and non-linearities in the relationship the following are also included: lagged values of 
the variables, interactions of each variable with per capita income, and squared terms on each 
explanatory variable. 
Hence the reduced form health equation is: 
4 4
1it it t i it
2x xϕ ρ ξ ω−= + + + +Ρ v
                                                
 (8) 
 
7 A formulation that included current income, thereby specifying a simultaneous model with the growth 
equation, was examined. However current income was never significant in the empirical estimation of the 
health equation, hence this variable was omitted and consequently the system of growth and health 
equations are not simultaneously determined. 
8 It is arguable whether HIV and malaria are exogenous determinants of the overall health outcome. Hence 
the choice of instruments for the instrumental variables estimation is tested in the empirical section of the 
paper; the test results suggest that we can have confidence in the overall set of instruments used. 
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where 
4
2
= ln , the log of health capital per 'effective' labour unit;
vector of exogenous variables (set text above.); 
time effects;
country specific fixed effects; and
standard error term.
it it
t
i
it
x h
v
ξ
ω
=
=
=
=
P
 
As with the macroeconomic growth model, the equation for health capital does not 
encompass potentially important distributional questions. Simple national average measures 
of the explanatory variables may not be appropriate in circumstances where there are wide 
differences in the standard of living, access to health care systems and incidences of disease 
within countries. While these questions are relevant they are beyond the scope of this study.9
4. Analysis 
Data  
The main source of data was the World Bank (1999). The income data are real GDP per 
capita adjusted for purchasing power parity, which are an update of the Penn World Tables 
(PWT) (see Summers and Heston, 1988 and 1991) developed using data from the Global 
Development Finance & World Development Indicators databases. The population (POP) 
data are those reported in World Development Indicators (World Bank, 2001). The PWT 
series for real GDP per worker and number of workers series were not updated beyond 1990, 
and hence it was not possible to use such series. The data for investment rates were calculated 
from current price data on GDP and domestic investment reported in World Development 
Indicators (World Bank, 2001). Rates of growth for GDP and population were estimated by 
log linear regression of the GDP and population series. There are four education series, 
primary school enrolment rates, secondary school enrolment rates and tertiary enrolment 
rates, which were from World Development Indicators (World Bank, 2001), and estimates of 
the average years of schooling (Barro and Lee, 2000).10
Data for the health capital equation are limited in terms of both coverage of countries and 
length of time series. Two alternative variables are used as a proxy for health capital. The first 
is life expectancy at birth, which is defined as the mean age at death of a fictitious generation 
subject to the mortality conditions of the period considered; this is expressed as the shortfall 
of life expectancy relative to a nominal benchmark, i.e., LE = - ln(80 – life expectancy) . This 
                                                 
9 Arndt and Lewis (2001) and Arndt (2002) are studies that emphasise distributional issues. 
10 Barro and Lee’s (2000) series of average years of schooling made no substantive difference to the 
empirical results and consequently the results using the more commonly used enrolment data are reported. 
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proxy has been defended by Sen (1998), but can be criticised for making “no allowance for 
the quality of health beyond survival” (Knowles and Owen, 1995, p 102). In the present 
context it would be expected that changes in life expectancy would understate changes in 
health capital resulting from HIV/AIDS by not registering the morbidity affects. The second 
health capital proxy is the infant mortality rate, defined as the number of infant deaths before 
one year of age per 1,000 live births. This proxy can be defended on the grounds that it offers 
an indicator of the current health status of the population through those most susceptible to 
deterioration in the general level of health within the population. As such it partially captures 
the ‘quality of health’ dimension, but it may overstate changes in health capital since it is 
arguable that a mother’s health may have a greater impact upon infant mortality and there is 
evidence of a greater prevalence rate among women in countries with higher overall 
prevalence rates. Neither proxy is ideal since both are likely to have involved some 
interpolation and hence may not fully reflect current health status and to a greater or lesser 
extent fail to capture ‘quality’ effects. On balance the preferred data set is infant mortality, 
but both were used in the estimation process although only the results for infant mortality are 
reported in detail. Both data series were obtained from World Development Indicators (World 
Bank, 2001). 
Table 1 HIV Prevalence Data (unweighted percentage rates for populations 15-49) 
About Here 
Time series estimates for number of adults (15-49) who were HIV positive were obtained 
from UNAIDS (Walker, 2000). These figures for prevalence levels were derived using an 
epidemiological model (EPIMODEL, Chin and Lwanga, 1991); the key data used to calibrate 
the model for each country include: point prevalence estimates for 1994 and 1997; the year 
‘extensive spread’ of infection started; the most likely shapes of the country specific 
epidemiological curves for the HIV prevalence over time; progression rates and age structure 
of the HIV-infected population. The method used and its strengths and weaknesses are 
discussed extensively in Schwartlander et al., (1999, pp 2455-2457). The HIV prevalence 
rates have been a subject of considerable recent research and are increasingly based on robust 
epidemiological data, e.g., blood samples taken at ante-natal clinics; indeed the “HIV sentinel 
surveillance systems are generally rather extensive when compared with surveillance systems 
for other communicable diseases” (Swartlander et al., 1999, p 2455). Consequently it is 
claimed that the current estimates of HIV prevalence are superior to estimates for the 
prevalence of other diseases (see Garnett et al., 2001), although clearly there are general 
issues about the quality of information about the prevalence of all communicable diseases. 
The data series were for all years from the start of the epidemic in each country up to 1999, 
and are expressed as prevalence rates among the adult population for use in the econometric 
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estimations. Summary statistics for the HIV prevalence data are reported in Table 1; these 
confirm the extent to which the epidemic is most pronounced in Africa and Latin America 
and the Caribbean, with all those countries in the latter sample with prevalence rates greater 
than one percent in 1999 being in the Caribbean basin. 
The malaria data record the proportions of the population at risk from malaria (MAL) 
because they live in areas of the country where malaria is present (Hamoudi and Sachs, 
1999).  Data are only available for 4 points in time (1946, 1966, 1982 and 1994): hence the 
proportions of population at risk during the intervening years were interpolated and the 
interpolated series was used to derive 5 yearly averages. Protein supplies per capita, a proxy 
for nutritional status, were compiled using data from the FAO’s FAOSTAT database (FAO, 
2000). All the variables are in logarithms. 
The database consists of time series data for 112 countries over the period 1960 to 1998, 
although for a number of variables the data are only available at 5 yearly intervals. There are 
five sub-samples; an 80-country developing world sample, a 21-country OECD sample, a 16-
country Asia sample, a 39-country Africa sample and a 24-country Latin America and 
Caribbean sample. This last sample is arguably the least convincing of the five since it 
encompasses South America, Central America and the Caribbean islands, regions that contain 
countries that may be geographically proximate but are arguable economically diverse. 
Alternative samples were explored, although in no cases were countries added to or dropped 
from samples on the basis of the econometric estimates. The most notable omissions from the 
sub-samples are the former communist block eastern and central European countries and a 
few middle eastern economies. In both cases the sample sizes were too small to generate 
meaningful results.11 The countries and the sub-samples are detailed in Appendix II. 
Econometric Method 
As explained in section 3 above, the model is comprised of a system of two equations, a 
structural growth equation based on the augmented Solow model (6) and a reduced form 
health equation (8) used to estimate the effect of HIV on the chosen measure of health capital. 
There are three main econometric issues for consideration. First, the health capital term ( )it4x  
is an endogenous variable in the growth equation (6) and thus is contemporaneously 
correlated with the errors ( , resulting in biased and inconsistent estimates via OLS. 
Second, the health (8) and growth (6) equations are both dynamic models containing lagged 
dependent variables. The presence of a lagged dependent variable also results in biased and 
inconsistent parameter estimates via OLS. And third, given the panel nature of the data, 
individual country heterogeneity must be dealt with in the estimation procedure; failure to 
)itv1
                                                 
11 Consideration was given to a European sample but it was concluded that this was more a geographic than 
an economic construct. 
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account for unobservable heterogeneity imposes invalid restrictions on the coefficient 
estimates. These three issues are interdependent; the approach adopted has the primary aim of 
producing consistent estimates of the effect of HIV/AIDS on growth, while avoiding 
unnecessary complexity in estimation and also retaining the theoretical interpretation of the 
parameters of the augmented Solow growth model. 
Instrumental variables estimation is used in two stages to deal with both the endogeneity 
of the health variable in the growth equation and the presence of lagged dependent variables 
in both the growth and health equations. In the first stage a reduced form health equation (8) 
with health capital as a function of exogenous variables and a lagged dependent variable is 
used to obtain predicted values for the health capital variable ( )ˆit4x . Instrumental variable 
regression is also employed at this stage to overcome the problems with the lagged dependent 
variable in the health equation. Here the lagged dependent variable is instrumented using the 
exogenous variables in the model and further lags on the health term. In the second stage the 
predicted values of the health capital variable ( 4ˆitx  from equation 8) are used to replace the 
health term ( )4itx  in the growth equation (6), thus dealing with the endogeneity of health 
capital in this model. The growth equation is also estimated via the instrumental variable 
approach in order to deal with the lagged dependent variable. 
Breusch-Pagan (BP) (Breusch and Pagan, 1980) and Hausman (H) (Hausman, 1978) tests 
are used to assess the need for country specific effects. If the Breusch-Pagan test is rejected 
time invariant country specific effects are included to account for unobservable heterogeneity. 
The Hausman tests confirm that fixed effects are the appropriate specification in each case. 
Where country specific effects are required the dynamic panel data model is estimated using 
the technique proposed by Arellano and Bond (1991). First differencing removes the time 
invariant country specific effects producing an equation that is estimable using instrumental 
variables. The Arellano and Bond generalised method of moments estimator employs lagged 
levels of the dependent variable and the predetermined variables and differences of the 
strictly exogenous variables to instrument the lagged dependent variable. This estimator has 
been shown to perform well in macro panels of this type (Judson and Owen, 1999). Where 
country specific effects are deemed unnecessary by the BP test, the data are pooled and the 
models are estimated by a standard instrumental variable approach. Again, lagged levels of 
the dependent variable and predetermined variables, as well as the strictly exogenous 
variables, are used as instruments for the lagged dependent variable. 
It is not possible to test empirically whether the instruments are exogenous. However, 
given that we have more instruments than are needed to identify each equation we employ the 
Sargan (1958) test for over-identifying restrictions to test the conditional validity of the 
additional instruments. Failure to reject the null hypothesis means we can have ‘some 
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confidence’ in the overall set of instruments used (Wooldridge, 2002: p123). In addition, for 
the standard instrumental variables regressions a generalised Hausman test is used to test for 
inconsistency of OLS estimates and thus confirm the need for the instrumental variable 
approach. 
Given the strong theoretical basis underlying the growth model, variables have been 
retained in the growth equations even when the empirical results reveal them to be 
insignificant or where signs are contrary to theoretical expectations. Since the health equation 
is a reduced form the results reported here were derived using a general to specific approach 
to find the most parsimonious model that explains the chosen health capital variable in each 
sample, with variables retained only if the coefficients were significant  at 5%. The full set of 
variables initially included lagged health (the lagged dependent variable, lnINF t-1), HIV 
prevalence (HIV), current income (lnYC), lagged income (lnYCt-1), the proportion of the 
population at risk of malaria (lnMAL), protein intake (lnPRO), the secondary school 
enrollment rate (lnSEN); in addition interactions of HIV prevalence, protein intake, risk of 
malaria, school enrollment rate with income and squared terms on each explanatory variable 
were also included. The health equations were estimated using both infant mortality and life 
expectancy as the dependent variable. 
All the estimates were derived using Stata v.8. A table of variable definitions and data 
sources is given in Appendix I.  
Results 
The models are estimated using five yearly average panel data for six samples for the period 
1960-1998 (eight time points). The results are reported in Table 2. The upper part of the table 
reports the results for the growth equation (6), where the dependent variable is the level of 
income per capita at the end of each five-year period (lnzit). The lower half shows the results 
for the reduced form health equation; the dependent variable in this case is the log of infant 
mortality (lnINF). The predicted values from the health equation are then used as the health 
variable term in the growth equation (pred lnINF).  
Table 2 Results from growth models (using infant mortality) 
About Here 
Country specific fixed effects are included in the health and growth equations for the 
World and Developing World samples, as signified by the results of the BP and H tests. They 
are also included in the growth equation for the Asia sample; all other equations are estimated 
using pooled data. All equations include time specific effects where these were significant at 
5 percent, but they are not reported here. All equations except the growth equation for the 
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World sample pass the Sargan test for over-identifying restrictions (although the result for the 
health equation for Latin America is marginal). For all of the pooled equations a generalised 
Hausman test shows that OLS is an inconsistent estimator in this context, which supports the 
use of the instrumental variable approach12.  
Consider first the reduced form health equations in the lower half of the table. The lagged 
dependent variable (lnINFt-1) is strongly significant in all cases. For the World, Asia and 
Africa samples lagged income (lnYCt-1) is also negatively related with infant mortality. In the 
Africa sample the proportion of the population at risk of malaria (lnMAL) exerts a positive 
influence on infant mortality while protein intake (lnPRO) has a negative influence. HIV 
prevalence is found to have a significant positive effect on infant mortality in the World, 
Developing World, Africa and Latin America; although the coefficient in this latter sample 
seems unfeasibly large. 
The growth equation results return the expected positive and significant coefficients for 
the savings/investment variable (lnI) in all samples except for Latin America & Caribbean, 
where it is insignificant. All the samples return positive and strongly significant coefficients 
on the lagged income term, which indicates that convergence is taking place, with the 
convergence rates given by the parameter, λ. The coefficient for ‘capital 
widening’/‘workforce growth’ (ln(n+g+δ)) is positive and significant for the World and 
OECD samples, which is contrary to expectations, but negative and significant in the Asia 
sample; elsewhere it is insignificant. The coefficient on the education capital proxy (lnSEN) is 
insignificantly different from zero in all cases. This finding is robust to the omission of the 
health capital term. 
The effects of health capital on growth, through the predicted infant mortality term (pred 
lnINF), are uniformly negative, and are strongly significant for the World, Developing World, 
Africa and Latin America samples. These results are robust to the omission of the education 
capital term, except for Latin America, where health capital is not significant when education 
capital is omitted from the growth equation. In all cases where health capital has a significant 
effect on growth the corresponding effects of HIV on infant mortality are significant and 
positive. 
The marginal impact of HIV prevalence and malaria on growth can be estimated from the 
coefficients; in all cases the signs are consistent with expectations. These impact estimates are 
reported as the rows ‘HIV Impact’ and ‘Malaria Impact’ in Table 2; the interpretation is that 
the impact estimates are the percentage change in income per capita for a one percent change 
in the HIV prevalence rate or the proportion of the population at risk to malaria. Since HIV 
                                                 
12  No equivalent test is available for the dynamic panel models estimated using the Arellano and Bond 
procedure. 
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and malaria have no statistically significant effects on infant mortality for the OECD and Asia 
samples the impacts on growth are also zero. Elsewhere the HIV impacts are negative, with 
Africa recording an average reduction of 0.59 percent in income per capita for one percent 
increase in HIV prevalence, while the World and Developing World sample indicate negative 
impacts of 0.05 and 0.08 percent. The very large impact of HIV prevalence in the Latin 
American sample is overwhelmingly a consequence of the large coefficient on HIV in the 
infant mortality equation, whose reliability we have statistical reason to doubt. The malaria 
impact is also negative for Africa, where a one percent increase in the proportion of the 
population at risk has a marginal impact of 0.37 percent on income per capita. 
The results using life expectancy (LE) as the health variable are not shown here. This 
alternative formulation resulted in no substantive differences to the results reported in Table 
2. In particular, for the growth equations the estimated coefficients on predLE are almost 
equal and opposite to those reported for predlnINF, hence the estimated marginal impacts of 
HIV prevalence are also very similar.   
5. Discussion 
The health capital and growth estimating equations confirm the importance of investigating 
heterogeneity across countries in macro econometric analyses. The results obtained during 
this analysis for the health capital equation are broadly consistent with expectations. The lack 
of any significant determinants of infant mortality other than lagged infant mortality in the 
OECD sample is consistent with an argument that above a certain income level the less 
important are the other/general economy wide factors for infant mortality.13 In the other 
samples, where incomes per capita are lower, there is some evidence that income levels in 
previous periods do have positive effects upon infant mortality, which is also consistent with 
expectations, but this is made less clear cut by the lack of significant coefficients for the 
Developing World sample. This conclusion is further reinforced by the results for the poorest 
region – Africa – where the effect of nutrition upon infant mortality is strongly negative, 
which is again consistent with expectations. Somewhat less satisfying is the fact that the 
interaction terms between nutrition levels and malaria with HIV prevalence were not 
significant, which may be contrary to expectations. The literature indicates that susceptibility 
to HIV infection increases as the general health status declines but that the onset of full blown 
AIDS is faster the less good is the general state of health; these results do not disprove this 
since we would expect these two features of the relationship between general health states and 
HIV to produce counteracting effects upon infant mortality. 
                                                 
13 One dimension that would have been useful to include in the health equations is income distribution, but 
adequate data are not available. If the income distribution effects are time invariant country-specific 
effects they are removed by a fixed effects specification, this is only relevant for the World and Dev 
eloping World samples (and growth for Asia). 
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The impact of HIV upon infant mortality is positive and strongly significant in the World, 
Developing World and Africa samples but does not have significant effects in Asia or the 
OECD sample. It is expected that the infant mortality is more closely related to the HIV 
prevalence rate among women than the general population. Since the characteristics of the 
HIV epidemic are different in the OECD and Asia where the ratios of women to men infected 
are very much lower than in Africa, these results are consistent with expectations. The impact 
of malaria is also positive and strongly significant for the Africa, but for no other sample. 
This is consistent with expectations given the greater proportions of the population at risk to 
malarial infection and the lower income levels. 
The weakest results are those for the Latin America and Caribbean sample. Neither the 
health capital nor the growth equation for this sample perform well compared to the equations 
for the other samples, and these results produce an unrealistic estimate for the marginal 
impact of HIV of 3.58. The origins of this apparently overlarge estimate are in the health 
capital equation where the lagged infant mortality effect is not ameliorated by the lagged 
income term and hence the impact of the large coefficient on HIV is not damped down as 
much as for the other samples. It is suspected that this is an inappropriate sample wherein the 
objective of grouping similar countries has not been achieved; indeed there are reasons to 
believe that this might be the case in the HIV data where all those countries with prevalence 
rates greater than 1 percent are in the Caribbean basin while rates in South America peak at 
0.67 percent (Argentina). Moreover the fact that this sample only marginally passes the 
Sargan test suggests that the instruments may not be ideal. So as to check that this sample of 
countries did not have any adverse implications for the results from the World and 
Developing World samples, of which they are subsets, the equations for a second pair of 
World and Developing World samples that excluded Latin America and the Caribbean were 
also estimated. These are reported in Table AIII in Appendix III. The only notable effect is 
that the coefficient on the predicted infant mortality term in the growth equations for the 
second World sample (World 2) is not quite significant. Because of doubts about the Latin 
America and the Caribbean sample the subsequent discussion does not refer explicitly to the 
results for that sample. 
The performance of the growth equation is interesting. In all cases, except for the Latin 
America and Caribbean sample, investment (I) in physical capital has a positive and 
significant effect that is roughly inversely related to income levels, which is in accordance 
with expectations and fully consistent with the evidence of convergence that is recorded by 
the positive signs on λ. The conditional convergence evidence is also consistent with 
expectations and the lagged income terms are all positive and significant. The degree of 
convergence is greater in the World and Developing World samples than in the OECD, Asia 
and Africa samples, which reflects the wider (relative) variations in incomes per capita in the 
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first two samples than in the latter three samples. However there is no evidence that 
investment in education capital through secondary school enrollment has the expected 
positive effect on growth, although this is a typical result for this variable in this type of cross 
country study (Bhargava et al. 2002; McDonald and Roberts 2002; Knowles and Owen, 1995; 
Islam, 1995). Despite this being a common result it is disturbing since it so strongly 
contradicts expectations; however it is a variable for which it is difficult to obtain truly 
satisfying data. Clearly education is not a perfect measure of the skill component of human 
capital and hence any education based measure is questionable, but it is very difficult to 
define precisely other measures of skills. It may also be argued that it is the skill stock of the 
current workforce that is relevant since this should directly influence the flow of skilled 
labour services currently available, whereas measures of investment in the skills of a future 
workforce, for which school enrolment rates are proxies, may be misleading. However use of 
a stock measure14 in this case made no substantive difference to the results and hence the 
coefficients for the secondary school rates were reported. 
The impact of predicted infant mortality on income is always negative, which is consistent 
with expectations that increases in health capital have positive implications for income, 
although the coefficients are insignificant for the OECD and Asia samples. But, there are 
reasons to believe that health capital may be less important in relatively wealthy economies 
and this is supported by the evidence that the lagged infant mortality and income variables 
returned significant coefficients in the health capital equations for the OECD and Asia 
samples while the coefficients on the income variables for the Asia sample were also 
significant. For the World, Developing World and Africa samples the negative infant 
mortality coefficients are all strongly significant, and, since the HIV variable returned 
significant effects in the health equations, it means that for these samples it is possible to 
estimate the marginal impact of HIV on incomes. Given the signs on the coefficients these are 
all negative effects. Moreover it is interesting to note that in all samples where HIV had a 
significant impact on life expectancy in the health capital equation, predicted infant mortality 
had negative and significant effects on income in the growth equation. A priori it would be 
expected given the HIV prevalence rates that the negative impact of HIV would be greater in 
Africa than the Developing World samples and greater in the Developing World than the 
World samples; these expectations are fulfilled by the results. Furthermore the estimated 
impact effects suggest that the marginal impact of HIV on incomes may increase with 
prevalence rates, which is an intuitively reasonable conclusion. 
                                                 
14  The stock measure was average years of schooling (Barro and Lee, 2000).  
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6. Concluding Comments 
The pronounced impact of HIV/AIDS prevalence on health capital/infant mortality, and hence 
on incomes, suggests that the epidemic may now be entering a stage where the loss of life is 
starting to impact appreciably upon both social and economic interactions. These results 
suggest that the seemingly comforting conclusion that excess labour supplies in many 
developing countries would be sufficient to ensure that the macroeconomic impacts of the 
HIV/AIDS epidemic might be relatively muted does not appear to be holding. However, there 
are difficulties with this type of broad brush analyses; especially the dependence of the model 
specification upon the presumption of steady state relationships. In particular the results 
indicate that there are substantial differences between regions, which points to the importance 
of a careful consideration of samples and sub-samples in order to gain a fuller picture of the 
relationship between HIV/AIDS and economic performance. Among the least satisfactory 
aspects of the results is the absence of significant coefficients on the education capital terms 
in the growth equations; while this is common in the literature it continues to be unsettling. 
The results also indicate the need for further explorations of how the epidemic impacts upon 
economic relationships, so as to direct policy makers’ attention to the economic implications 
of AIDS. In the longer term it is argued that there is a need for research that provides a greater 
understanding of the mechanisms by which sustained epidemics impact upon economic 
performance. Such a research agenda will necessitate the development of forward looking 
models that provide insights into how, inter alia, the large numbers of AIDS orphans will 
impact upon the accumulation of education capital (Bell et al., 2003, may provide a start for 
this type of research). 
Nevertheless, these results produce useful additional information and indicate that the 
macroeconomic affects of the HIV/AIDS epidemic are substantial. In the countries of the 
Africa sample, where HIV and malaria are health problems on a scale that OECD countries 
might regard as catastrophic, the level of the marginal impacts of HIV prevalence on income 
pre capita are of orders of magnitude that suggest that a substantial proportion of the 
apparently poor economic performance of many of these economies over the past 10 to 20 
years can be attributable to the HIV epidemic; a characteristic that has been omitted from 
many macroeconometric studies that have sought to explain economic performance in many 
developing countries. Moreover the marginal effects are sufficiently large to suggest that they 
threaten macroeconomic stability, which is generally most fragile in the poorer countries that 
are also those most prone to catastrophic escalations of the epidemic. If the legitimate 
aspirations of the inhabitants of these countries are to be achieved and poverty reduction 
strategies, and similar policies, in these countries are to be realised, the maintenance of 
macroeconomic stability is likely to be a prerequisite. All of which indicates that over and 
above the humanitarian case for supporting healthcare provision and services in countries 
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suffering from the HIV/AIDS pandemic, there is a strong case for providing more general 
economic support. 
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Table 1 HIV Prevalence Data (unweighted percentage rates for populations 15-49) 
  1984 1989 1994 1999 
World Average 0.09 1.08 2.17 3.26 
 Std Deviation 0.39 2.16 4.32 6.49 
 Max 3.52 12.04 24.09 36.13 
Developing World Average 0.13 1.51 3.03 4.56 
 Std Deviation 0.46 2.45 4.89 7.36 
 Max 3.52 12.04 24.09 36.13 
OECD Average 0.03 0.09 0.15 0.22 
 Std Deviation 0.04 0.09 0.13 0.18 
 Max 0.13 0.29 0.45 0.61 
Asia Average 0.00 0.08 0.18 0.28 
 Std Deviation 0.00 0.17 0.35 0.52 
 Max 0.00 0.70 1.40 2.10 
Africa Average 0.21 2.83 5.73 8.63 
 Std Deviation 0.66 3.00 5.96 8.96 
 Max 3.52 12.04 24.09 36.13 
Latin America Average 0.08 0.41 0.74 1.07 
 Std Deviation 0.09 0.45 0.82 1.20 
 Max 0.34 1.91 3.51 5.11 
Source: Authors calculations from Walker (2000) 
 21
Table 2 Results from growth models (using infant mortality) 
 World 
i = 112 
n = 684 
Developing 
World 
i = 80 
n = 518 
OECD 
i = 21 
n = 109 
Asia 
i = 16 
n = 107 
Africa 
i = 39 
n = 259 
Latin 
Am& 
Caribbean 
i = 24 
n = 164 
Income (lnYC)       
lnI 0.219* 0.238* 0.091* 0.245* 0.168* -0.024 
 (0.035) (0.030) (0.044) (0.091) (0.022) (0.064) 
ln(n+g+d) 0.182* 0.004 0.153* -0.667* 0.001 0.180 
 (0.087) (0.094) (0.079) (0.254) (0.103) (0.170) 
lnSEN -0.012 -0.045 0.003 -0.147 0.016 0.073 
 (0.037) (0.024) (0.072) (0.098) (0.018) (0.051) 
pred lnINF -0.130* -0.178* -0.056 -0.131 -0.092* -0.087* 
 (0.059) (0.059) (0.037) (0.094) (0.046) (0.043) 
lnYCt-1 0.653* 0.631* 0.869* 0.829* 0.908* 0.966* 
 (0.064) (0.094) (0.029) (0.084) (0.027) (0.037) 
λ 0.053 0.058 0.018 0.023 0.012 0.004 
HIV Impact -0.050 -0.082 0.000 0.000 -0.585 -3.582 
Malaria Impact 0.000 0.000 0.000 0.000 -0.366 0.000 
R2 N/A N/A 0.96 N/A 0.96 0.94 
Sargan 39.64 
[.023] 
27.72 
[.148] 
2.247 
[.523] 
11.37 
[0.979] 
0.174 
[.676] 
5.44 
[.365] 
BP 19.91 
[.000] 
7.53 
[.006] 
1.16 
[.282] 
13.32 
[.000] 
0.22 
[.638] 
0.21 
[.645] 
H 65.04 
[.000] 
60.49 
(.000) 
 200.40 
[.000] 
  
Infant Mortality (lnINF)      
lnINFt-1 0.805* 0.888* 0.877* 0.998* 0.885* 0.920* 
 (0.043) (0.039) (0.032) (0.027) (0.038) (0.029) 
lnYCt-1 -0.044*   -0.088* -0.074*  
 (0.25)   (0.027) (0.014)  
HIV 0.024* 
(.004) 
0.019* 
(.004) 
  0.024* 
(.004) 
0.112* 
(.042) 
lnMAL     0.015* 
(.006) 
 
lnPRO     -0.119*  
     (0.037)  
R2   0.96 0.98 0.94 0.94 
Sargan 49.56 
[.333] 
36.26 
[.847] 
3.555 
[.615] 
4.242  
[.236] 
6.638 
[.084] 
10.92 
[.053] 
BP 15.14 
[.000] 
10.15 
[.001] 
1.17 
[.280] 
0.21 
[.645] 
2.01 
[.156] 
0.26 
[.612] 
H 69.12 
[.000] 
174.42 
[.000] 
    
The variable pred ln(INF) in the growth equation are the predicted values from the health equation shown in the 
lower panel.  
Where both Breusch-Pagan (BP) and Hausman (H) tests are rejected, country specific fixed effects are included. 
Where the BP test is not rejected the estimates are from simple pooled data.  
Time specific effects are included if significant at 5%. Time specific and country specific effects are not reported 
here.  
* denotes significance at 5% 
Where individual effects are required the equations are estimated using the XTABOND procedure in STATA 
v.8. Pooled models are estimated using IVREG.  
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Appendix 1 
Variable Definitions and Data Sources  
 
Variable Definition Source 
YC Real GDP per capita World Bank Macroeconomic Series – 
updated PWT data 
I Share of real GP invested Global Development Finance & World 
Development Indicators 
(n + g + d)  
 
n = rate of growth of population  
g = rate of growth of technology 
d = depreciation rate of all capital stocks 
World Bank Macroeconomic Series – 
updated PWT data 
SEN Secondary school enrollment rate (gross) World Data, (World Bank 2001) 
INF Infant mortality World Data, (World Bank 2001) 
LE Shortfall in life expectancy World Data, (World Bank 2001) 
HIV HIV prevalence rate Derived from UNAIDS figures by Walker 
(2000) 
MAL Proportion of population living in areas where 
malaria is prevalent 
Data from Centre for International 
Development (Hamoudi and Sachs, 1999). 
PRO Protein per Capita per day (gms) FAO 
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Appendix II Samples 
Country Groups Country Groups Country Groups 
United Arab Emirates DW, AS United Kingdom O Namibia DW, AF 
Argentina DW, LAC Ghana DW, AF Niger DW, AF 
Australia O Gambia, The DW, AF Nigeria DW, AF 
Austria O Guinea-Bissau DW, AF Nicaragua DW, LAC 
Burundi DW, AF Greece O Netherlands O 
Belgium O Guatemala DW, LAC Norway O 
Benin DW, AF Guyana DW, LAC Nepal DW, AS 
Burkina Faso DW, AF Hong Kong, China DW, AS New Zealand O 
Bangladesh DW, AS Honduras DW, LAC Pakistan DW, AS 
Bulgaria  Haiti DW, LAC Peru DW, LAC 
Belize DW, LAC Hungary  Philippines DW, AS 
Bolivia DW, LAC Indonesia DW, AS Papua New Guinea DW , AS 
Brazil DW, LAC India DW, AS Poland  
Barbados DW, LAC Iran, Islamic Rep. DW, AS Paraguay DW, LAC 
Botswana DW, AF Iceland O Romania  
Central African Republic DW, AF Israel  Rwanda DW, AF 
Canada O Italy O Saudi Arabia  
Switzerland O Jamaica DW, LAC Sudan DW, AF 
Chile DW, LAC Japan O Senegal DW, AF 
China DW, AS Kenya DW, AF El Salvador DW, LAC 
Cote d'Ivoire DW, AF Korea, Rep. DW, AS Suriname DW, LAC 
Cameroon DW, AF Kuwait  Sweden O 
Congo, Rep. DW, AF Sri Lanka DW, AS Swaziland DW, AF 
Colombia DW, LAC Lesotho DW, AF Syrian Arab Republic  
Costa Rica DW, LAC Luxembourg O Chad DW, AF 
Cyprus  Latvia  Togo DW, AF 
Czech Republic  Morocco DW, AF Thailand DW, AS 
Denmark O Madagascar DW, AF Trinidad and Tobago DW, LAC 
Dominican Republic DW, LAC Mexico DW, LAC Tunisia DW, AF 
Algeria DW, AF Mali DW, AF Turkey  
Ecuador DW, LAC Malta O Uganda DW, AF 
Egypt, Arab Rep. DW, AF Myanmar DW Uruguay DW, LAC 
Spain O Mozambique DW, AF United States O 
Finland O Mauritania DW, AF Venezuela DW, LAC 
Fiji DW, AS Mauritius DW, AF South Africa DW, AF 
France O Malawi DW, AF Congo, Dem. Rep. DW, AF 
Gabon DW, AF Malaysia DW, AS Zambia DW, AF 
    Zimbabwe DW, AF 
DW – Developing  World; O – OECD; AS – Asia; AF – Africa; LAC – Latin America and Caribbean. 
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Appendix III 
Table AIII Additional Results From Growth and Health Capital Models 
 World (2) 
i = 92 
n = 532 
Developing 
World (2) 
i = 56 
n = 518 
 World (2) 
i = 92 
n = 532 
Developing 
World (2) 
i = 56 
n = 518 
Income   Infant 
Mortality 
  
ln(I) 0.249* 0.252* ln(INF)t-1 0.847* 0.977* 
 (0.041) (0.036)  (0.045) (0.043) 
ln(n+g+d) 0.216* -0.016 ln(YC)t-1 -0.046*  
 (0.096) (0.107)  (0.27)  
ln(SEN) -0.054 -0.060 HIV2 0.026* 
(.004) 
0.020* 
(.005) 
 (0.040) (0.036) ln(MAL)   
pred 
ln(INF) 
-0.117 -0.200* ln(PRO)   
 (0.068) (0.074)    
ln(YC)t-1 0.643* 0.667*    
 (0.068) (0.095)    
      
λ 0.055 0.051    
HIV 
Impact 
-0.062 -0.522    
      
R2   R2   
Sargan 34.58 
[.043] 
22.86 
[.351] 
Sargan 45.39 
[.497] 
23.16 
[.281] 
BP 8.10 
[.004] 
3.71 
[.054] 
BP 25.24 
[.000] 
9.07 
[.003] 
H 140.89 
[.000] 
157.96 
(.000) 
H 65.43 
[.000] 
28.20 
[.000] 
 
 
Appendix IV 
If the labour forces grow at the constant rates ni, and technologies advance at period specific 
constant rates gt i.e., the growth rates of labour and technology are country- and time-period 
specific, and the physical, education and human capital stocks depreciate at the same constant 
rate, δ, then 
1,1,
1,1,
1,1,
)1(
)1(
)1(
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. (A1.1) 
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If savings are divided between physical, education and human capital accumulation, i.e., 
education and health capital accumulation is treated as an investment activity, such that 
it
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K
itit Y
III
Y
I
Y
Sssss ++===++= . (A1.2) 
then the rates of physical, education and health capital growth per unit of labour are defined as 
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 (A1.3) 
and the steady state values of physical, education and health capital, indicated by asterisks, are 
( ) ( ) ( )
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and therefore 
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. (A1.5) 
Incorporating physical, education and health capital the augmented steady state output per 
capita is 
( )* 0ln ln ln(1 )
ln ln ln
(1 ) (1 ) (1 )
it i t i i
k E
i i
y A g t n g
s s His
α β ψ δα β ψ
α β ψ
α β ψ α β ψ α β ψ
+ += + − + +− − −
+ + +− − − − − − − − −
 (A1.6) 
which is equation 3 in the main text. 
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